Statistics for Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model
Total visits
| views | |
|---|---|
| Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model | 24 |
Total visits per month
| views | |
|---|---|
| May 2025 | 4 |
| June 2025 | 0 |
| July 2025 | 4 |
| August 2025 | 3 |
| September 2025 | 4 |
| October 2025 | 1 |
| November 2025 | 0 |
File Visits
| views | |
|---|---|
| hdl_139651.pdf | 5 |